SIRT1 and polycystic ovary syndrome: A study comparing the effects of metformin and resveratrol in mice with PCOS shows that both treatments do not affect the expression of SIRT1 and AMPK (target genes for resveratrol and metformin, respectively), yet equally improved ovarian structure with a consequent increase in corpus luteum and graft follicles58.